A pilot study to evaluate urine LAM assay for diagnosis of pulmonary tuberculosis among non-HIV patients

There is a great need to improve diagnostic tools for tuberculosis where the majority are without HIV co-infection in resource-poor settings and high-burden areas such as India. The urine LAM assay has not hitherto been studied and may have a role to play. Our study found that, as a stand-alone diagnostic tool, the assay was suboptimal when compared to Xpert MTB/Rif. However, a combination of LAM assay along with sputum microscopy may be useful in settings where molecular testing is unavailable.

[1]  N. Dendukuri,et al.  Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV , 2019, The Cochrane database of systematic reviews.

[2]  E. Szumilin,et al.  Should Urine-LAM Tests Be Used in TB Symptomatic HIV-Positive Patients When No CD4 Count Is Available? A Prospective Observational Cohort Study From Malawi , 2019, Journal of acquired immune deficiency syndromes.

[3]  Z. Udwadia,et al.  Tuberculosis in South Asia: a tide in the affairs of men , 2018, Multidisciplinary Respiratory Medicine.

[4]  S. Lawn,et al.  Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort , 2017, BMC Medicine.

[5]  Kausik Bhattacharyya,et al.  Rv1458c: a new diagnostic marker for identification of Mycobacterium tuberculosis complex in a novel duplex PCR assay , 2017, Journal of medical microbiology.

[6]  H. Tola,et al.  Performance of point-of-care urine test in diagnosing tuberculosis suspects with and without HIV infection in selected peripheral health settings of Addis Ababa, Ethiopia , 2017, BMC Research Notes.

[7]  S. Lawn,et al.  A breakthrough urine-based diagnostic test for HIV-associated tuberculosis , 2016, The Lancet.

[8]  V. Sreenivas,et al.  Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis , 2015, PloS one.

[9]  M. Hoelscher,et al.  Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing , 2015, BMC Infectious Diseases.

[10]  E. van Marck,et al.  Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults , 2015, PloS one.

[11]  Gita Nataraj,et al.  Utility of light-emitting diode microscopy for the diagnosis of pulmonary tuberculosis in HIV infected patients. , 2015, International journal of mycobacteriology.

[12]  S. Dorman,et al.  Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals , 2014, AIDS.

[13]  M. Viveiros,et al.  Assessment of the BD MGIT TBc Identification Test for the Detection of Mycobacterium tuberculosis Complex in a Network of Mycobacteriology Laboratories , 2014, BioMed research international.

[14]  A. Bhatnagar,et al.  Development of a Novel PCR Restriction Analysis of the hsp65 Gene as a Rapid Method To Screen for the Mycobacterium tuberculosis Complex and Nontuberculous Mycobacteria in High-Burden Countries , 2013, Journal of Clinical Microbiology.

[15]  A. Brent,et al.  Performance of the MGIT TBc Identification Test and Meta-Analysis of MPT64 Assays for Identification of the Mycobacterium tuberculosis Complex in Liquid Culture , 2011, Journal of Clinical Microbiology.

[16]  M. Fabre,et al.  Assessment of the SD Bioline Ag MPT64 Rapid™ and the MGIT™ TBc identification tests for the diagnosis of tuberculosis. , 2011, Diagnostic microbiology and infectious disease.

[17]  P. de Rijk,et al.  Evaluation of the BD MGIT TBc Identification Test (TBc ID), a rapid chromatographic immunoassay for the detection of Mycobacterium tuberculosis complex from liquid culture. , 2011, Journal of microbiological methods.